Shareholders deserve more than commitment... we deserve performance.

Obviously Kristi must have tired of her commitment.

As was pointed out earlier this week, all of the talk relating to potential of Agrastim sounds eerily familiar to the potential touted regarding NCS.

Anything short of documented financial performance is hype and conjecture.

Jeff